Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SafeBlood is an international healthcare organization that facilitates the provision of blood products from donors who have not received mRNA-based vaccines. Founded in 2022 by George Della Pietra, the organization operates a global network to connect patients with unvaccinated donors through a directed donation model. SafeBlood provides a membership-based platform that coordinates with medical clinics and professionals willing to perform transfusions using these specific blood sources. The organization aims to offer an alternative for individuals concerned about the safety of the general blood supply following mass mRNA vaccination campaigns. It currently maintains a presence in over 80 countries, focusing on patient advocacy and donor-recipient matching.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SafeBlood.